Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for delayed CINV prevention
NCT00880191Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Apr 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gabapentin in chemotherapy-induced nausea and vomiting (CINV), sponsored by Cancer and Leukemia Group B. Started Apr 2009; status: completed.
02
Drugs
gabapentin
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00880191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00880191.